With the coronavirus pandemic continuing to rage around the world, vaccines are the only way out. What can India do to boost COVID-19 vaccine manufacturing?
Despite a slowdown in India's Second Wave and relaxing of restrictions in the West, the pandemic continues to rage on. Will we ever eliminate COVID-19?
The US has said it will back a proposal at the WTO to waive patents on COVID-19 vaccines. What are the arguments for and against this proposal?
Richer nations have been hoarding coronavirus vaccines for months now. Will it serve their purposes? Or prove detrimental in the long run?
Pfizer, Moderna and Oxford have begun clinical trials of their COVID-19 vaccines on children. Is inoculating children crucial to ensure the end of the pandemic?
As the global vaccination effort against COVID-19 picks up steam, we may wonder: How do vaccine manufacturers make money?
What are the issues with the Covaxin vaccine? Was it approved too soon? Does it pose considerable challenges to public health and safety in light of its contentious efficacy?
Last week, scientists in the UK discovered a new strain of coronavirus. How is it different? Is vaccination effective against it? How has it affected world markets?
How will India play a central role in delivering COVID-19 vaccines to the world? How are pharma companies preparing for the surge in demand?
